Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Some human genetic markers work for genetic studies in pig-tailed and stump-tailed macaques, which can help in their conservation.

No single biomarker is reliable enough for diagnosing and assessing SLE.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The model accurately predicts age from saliva and buccal cells for forensic use.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

A new mRNA variant of the SCF gene in sheep skin produces a shorter, different protein.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

A woman's complete hair loss condition improved after recovering from COVID-19.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

A man with skin and hair symptoms improved partially with specific treatment.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Long COVID has severely affected a couple's health, finances, and social life.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Certain genes are linked to the risk of developing Alopecia Areata.

Coenzyme Q10 helps reduce aging in human hair.

EDA and EDAR are important for hair follicle development in cashmere goats and affect other related genes.